
Allyson Neel Trail
Examiner (ID: 2128, Phone: (571)272-2406 , Office: P/2876 )
| Most Active Art Unit | 2876 |
| Art Unit(s) | 2876 |
| Total Applications | 1933 |
| Issued Applications | 1628 |
| Pending Applications | 130 |
| Abandoned Applications | 210 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16976082
[patent_doc_number] => 20210220319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => VETERINARY COMPOSITIONS AND THE USES THEREOF FOR CONTROLLING IRON DEFICIENCIES IN NON-HUMAN MAMMALS
[patent_app_type] => utility
[patent_app_number] => 17/055869
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055869 | Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals | May 15, 2019 | Issued |
Array
(
[id] => 15553561
[patent_doc_number] => 20200061192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/400808
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400808 | DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS | Apr 30, 2019 | Abandoned |
Array
(
[id] => 16726479
[patent_doc_number] => 20210093626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => SERPIN INHIBITORS FOR THE TREATMENT OF PRION AND PRION-LIKE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/051385
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051385 | SERPIN INHIBITORS FOR THE TREATMENT OF PRION AND PRION-LIKE DISEASES | Apr 29, 2019 | Abandoned |
Array
(
[id] => 17007154
[patent_doc_number] => 20210238315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => CROSS-LINKED STARCH-BASED POLYMERS FOR DRUG-DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/049185
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049185 | Cross-linked starch-based polymers for drug-delivery | Apr 18, 2019 | Issued |
Array
(
[id] => 19089700
[patent_doc_number] => 11951119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Combination comprising zidovudine and an antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 17/051549
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8108
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051549 | Combination comprising zidovudine and an antimicrobial compound | Apr 11, 2019 | Issued |
Array
(
[id] => 15524921
[patent_doc_number] => 20200054766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
[patent_app_type] => utility
[patent_app_number] => 16/366408
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/366408 | Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same | Mar 26, 2019 | Abandoned |
Array
(
[id] => 16657470
[patent_doc_number] => 20210054106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => OMNIPHILIC NANO-VESICLES BASED ON MODIFIED POLYSACCHARIDES FOR DELIVERY OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/982827
[patent_app_country] => US
[patent_app_date] => 2019-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982827 | OMNIPHILIC NANO-VESICLES BASED ON MODIFIED POLYSACCHARIDES FOR DELIVERY OF ACTIVE AGENTS | Mar 23, 2019 | Abandoned |
Array
(
[id] => 16213917
[patent_doc_number] => 10729709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Injectable antibiotic formulations and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/359197
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359197 | Injectable antibiotic formulations and use thereof | Mar 19, 2019 | Issued |
Array
(
[id] => 14563979
[patent_doc_number] => 20190209596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => METHODS OF TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/353000
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353000 | METHODS OF TREATING DISEASES | Mar 13, 2019 | Abandoned |
Array
(
[id] => 14868131
[patent_doc_number] => 20190284307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/353979
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353979 | DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIES | Mar 13, 2019 | Abandoned |
Array
(
[id] => 17095377
[patent_doc_number] => 20210283168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/980064
[patent_app_country] => US
[patent_app_date] => 2019-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980064 | BETA GLUCAN AND CD40 AGONIST COMBINATION IMMUNOTHERAPY | Mar 12, 2019 | Pending |
Array
(
[id] => 14534385
[patent_doc_number] => 20190202814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN
[patent_app_type] => utility
[patent_app_number] => 16/295199
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295199 | PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN | Mar 6, 2019 | Abandoned |
Array
(
[id] => 16555704
[patent_doc_number] => 20210000852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => POLYDATIN PACLITAXEL COMPOSITION, AND APPLICATION IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING GASTRIC CANCER
[patent_app_type] => utility
[patent_app_number] => 16/975332
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975332 | POLYDATIN PACLITAXEL COMPOSITION, AND APPLICATION IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING GASTRIC CANCER | Feb 27, 2019 | Abandoned |
Array
(
[id] => 17953671
[patent_doc_number] => 11479765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Method of isolating exosomes using encapsulation and aqueous micellar system
[patent_app_type] => utility
[patent_app_number] => 16/961248
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5990
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961248 | Method of isolating exosomes using encapsulation and aqueous micellar system | Jan 17, 2019 | Issued |
Array
(
[id] => 14309559
[patent_doc_number] => 20190144483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/249203
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16249203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/249203 | Compositions and methods for treating infectious disease | Jan 15, 2019 | Issued |
Array
(
[id] => 16484093
[patent_doc_number] => 20200377694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => THERMOPLASTIC STARCH
[patent_app_type] => utility
[patent_app_number] => 16/961480
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961480 | Thermoplastic starch | Jan 10, 2019 | Issued |
Array
(
[id] => 16397226
[patent_doc_number] => 20200338084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/959804
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959804 | INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF | Jan 1, 2019 | Abandoned |
Array
(
[id] => 16504747
[patent_doc_number] => 20200384003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => TRITERPENOID-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/959084
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959084
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959084 | TRITERPENOID-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF | Dec 27, 2018 | Abandoned |
Array
(
[id] => 16686900
[patent_doc_number] => 20210069375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Extracellular Matrices, Uses thereof, and Method for Making Extracellular Matrices
[patent_app_type] => utility
[patent_app_number] => 16/958553
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958553
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958553 | Extracellular Matrices, Uses thereof, and Method for Making Extracellular Matrices | Dec 27, 2018 | Abandoned |
Array
(
[id] => 16288874
[patent_doc_number] => 10765697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Method and treating renal disease
[patent_app_type] => utility
[patent_app_number] => 16/227003
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 25
[patent_no_of_words] => 18810
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227003 | Method and treating renal disease | Dec 19, 2018 | Issued |